BodeyG. P.HewlettJ. S.ColtmanC. A.: Therapy of Adult Acute Leukemia with Daunorubicin and L-Asparaginase, Cancer33: 626–630 (Mar.) 1974.
2.
EvansA. E.BaehnerR. L.ChardR. L.: Comparison of Daunomycin (NSC-83142) with Adriamycin (NSC-123127) in the Treatment of Late-Stage Childhood Solid Tumors, Cancer Chemother. Rep.58: 671–676 (Sept.-Oct.) 1974.
3.
GluckmanE.BaschA.VaretB.: Combination Chemotherapy with Cytosine Arabinoside and Rubidomycin in 30 Cases of Acute Granulocytic Leukemia, Cancer31: 487–491 (Mar.) 1973.
4.
JaffeeN.TraggisD. G.DasL.: Daunorubicin (NSC-83142) in Advanced Childhood Leukemia, Cancer Chemother. Rep.58: 661–665 (Sept.-Oct.) 1974.
5.
KlenerP.DonnerL.KozenaJ.: Daunorubicin and Adriamycin in the Treatment of Leukemia, Neoplasma20: 87–96, 1973.
6.
WeilM.GlidewellO. J.JacquillatC.: Daunorubicin in the Therapy of Acute Granulocytic Leukemia, Cancer Res.33: 921–928 (May) 1973.
7.
WiernikP. H.SchimpffS. C.SchifferC. A.: Randomized Clinical Comparison of Daunorubicin (NSC-82151) Alone with a Combination of Daunorubicin, Cytosine Arabinoside (NSC-63878), 6-Thioguanine (NSC-752), and Pyrimethamine (NSC-3061) for the Treatment of Acute Nonlymphocytic Leukemia, Cancer Treat. Rep.60: 41–53 (Jan.) 1976.
8.
ChabnerB. A.MyersC. E.OliverioV. T.: Clinical Pharmacology of Anticancer Drugs, Seminars Oncol.4: 165–191 (June), 1977.
9.
JonesB.HollandJ. F.MorrisonA. R.: Daunorubicin (NSC-82151) in the Treatment of Advanced Childhood Lymphoblastic Leukemia, Cancer Res.31: 84–90 (Feb.) 1971.
10.
Whang-PengJ.LeventhalB. G.AdamsonJ. W.: The Effect of Daunomycin on Human Cells In Vivo and In Vitro, Cancer23: 113–121 (Jan.) 1969.
11.
WantzinG. L.KarleH.PhilipP.: The Effect of Daunomycin on Cell Proliferation and Protein Synthesis of Human Leukemic Blast Cells, Eur. J. Cancer12: 291–297 (Apr.) 1976.
12.
RusconiA.DiMarcoA.: Inhibition of Nucleic Acid Synthesis by Daunomycin and its Relationship to the Uptake of the Drug in HeLa Cells, Cancer Res.29: 1507–1511 (Aug.) 1969.
13.
TakanashiS.BachurN. R.: Daunorubicin Metabolites in Human Urine, J. Pharmacol. Exp. Ther.195: 41–49 (Oct.) 1975.
14.
HalazunJ. F.WagnerH. R.GaetaJ. E.: Daunorubicin Cardiac Toxicity in Children with Acute Lymphocytic Leukemia, Cancer33: 545–554 (Feb.) 1974.
15.
Von HoffD. D.RozencweigM.LayardM.: Daunomycin Induced Cardiotoxicity in Children and Adults, Am. J. Med.62: 200–208 (Feb.) 1977.
16.
I. BroderL. E.CarterS. K.: Pancreatic Cell Carcinoma II. Results of Therapy with Streptozotocin in 52 Patients, Ann. Intern. Med.79: 108–118 (July) 1973.
17.
DuPriestR. W.HuntingtonM. C.MasseyW. H.: Streptozotocin Therapy in 22 Cancer Patients, Cancer35: 358–367 (Feb.) 1975.
18.
MoertelC. G.ReitemeierR. J.SchuttA. J.: Phase II Study of Streptozotocin (NSC-85998) in the Treatment of Advanced Gastrointestinal Cancer, Cancer Chemother. Rep.55: 303–307 (June) 1971.
19.
ScheinP. S.O'ConnellM. J.BlomJ.: Clinical Antitumor Activity and Toxicity of Streptozotocin (NSC-85998), Cancer34: 993–1000 (Oct.) 1974.
20.
StadilF.StageG.RehfeldJ. F.: Treatment of Zollinger-Ellison Syndrome with Streptozotocin, N. Engl. J. Med.294: 1440–1442 (June 24) 1976.
21.
CarterS. K.BroderL.FriedmanM.: Streptozotocin Treatment of Carcinoid Tumors, Ann. Intern. Med.74: 445–446 (Mar.) 1971.
IwezeF. I.Owen-SmithM.PolakJ.: Carcinoid Syndrome Treated with Streptozotocin, Proc. R. Soc. Med.65: 164–165 (Feb.) 1972.
24.
BhuyanB. K.: The Action of Streptozotocin on Mammalian Cells, Cancer Res.30: 2017–2023 (July) 1970.
25.
RosenkrantzH. S.CarrH. S.: Differences in the Action of Nitrosomethylurea and Streptozotocin, Cancer Res.30: 112–117 (Jan.) 1970.
26.
HeinemannB.HowardA. J.: Effect of Compounds with both Antitumor and Bacteriophage-inducing Activities on E. Coli Nucleic Synthesis, Antimicrob. Agents Chemother.5: 488–492, 1965.
27.
AdolpheA. B.GlasoferE. D.TroetelW. M.: Fate of Streptozotocin (NSC-85998) in Patients with Advanced Cancer, Cancer Chemother. Rep.59: 547–556 (May-June) 1975.
28.
SadoffL.: Nephrotoxicity of Streptozotocin (NSC-85998), Cancer Chemother. Rep.54: 457–459 (Dec.) 1970.
